SBIR-STTR Award

Meal-Triggered Vagal Nerve Stimulation for Obesity
Award last edited on: 3/22/2016

Sponsored Program
SBIR
Awarding Agency
NIH : NIDDK
Total Award Amount
$207,513
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Jieyun None Yin

Company Information

Transtimulation Research Inc

921 NE 13th Street (VRF/151)
Oklahoma City, OK 73104
   (405) 270-0501
   jiandechen@transtimulation.com
   www.transtimulation.com
Location: Single
Congr. District: 05
County: Oklahoma

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2015
Phase I Amount
$207,513
?Obesity and its co-morbidities cause about 400,000 deaths and cost more than $140 billion per year in USA. However, current treatment options for obesity are very limited. Vagal nerve stimulation (VNS) as a potential therapy for treating obesity has been explored in both laboratory and clinical settings. However, there is lack of systematic studies investigating the effects of various stimulation parameters and configurations on food intake and body weight. Consequently, no clinically relevant methodologies are currently available. In this project, we propose an innovative method of VNS for treating obesity by optimizing methodologies and providing automated delivery of electrical stimulation upon food ingestion. Our preliminary data in obese rats have demonstrated a significant and clinically relevant weight loss, attributed to the inhibition in food intake. The main aim of this project is o prove the feasibility of the proposed VNS for treating obesity in a large animal model of obesity using an implantable pulse generator. Specific objectives are as follows: 1) to derive most effective parameters for VNS to inhibit food intake in a swine model of obesity. Experiments are designed to obtain most effective stimulation frequencies, pulse width and stimulation configurations; 2) to study the efficacy and safety of chronic VNS using optimized stimulation parameters in treating obesity in pigs and also to explore possible mechanisms involving autonomic functions, gastric motility and gastrointestinal hormones, such as orexigenic hormone, ghrelin, and anorexigenic hormones, glucagon-like peptide-1 and polypeptide YY; The performance of on-demand meal-triggered VNS method in reducing body weight will be compared with the conventional VNS; 3) to develop an algorithm and use it to detect food intake and automatically initiate VNS upon meal ingestion. It will be designed based on changes in autonomic functions upon food intake. The autonomic functions will be assessed using spectral analysis of the heart rate variability signal that is obtained from stimulation electrodes. A comprehensive and competitive team has been assembled with expertise in neuromodulation, software and device development, obesity, and surgery. A consulting statistician is also included in the team. The accomplishment of this project will prove the feasibility of the proposed method for treating obesity.

Public Health Relevance Statement:


Public Health Relevance:
Obesity is one of major health problems in the world with limited treatment options. In this project we propose a new method for the treatment of obesity by placing a pair of tiny wires on the vagus nerves. Such a weak electrical current generates feeling of fullness and satiety and the subject is going to eat less and lose weight.

NIH Spending Category:
Neurosciences; Nutrition; Obesity

Project Terms:
Acute; Adverse effects; Adverse event; Algorithms; Animal Model; bariatric surgery; base; Body Weight; Body Weight decreased; cell motility; Cessation of life; Charge; Chronic; Clinical; Clinical Research; clinically relevant; Comorbidity; Consult; Control Groups; cost; Data; design; Detection; Device or Instrument Development; Devices; Diet; Eating; effective therapy; Electric Stimulation; Electrodes; Epilepsy; Failure (biologic function); Family suidae; Feeling; Food; Frequencies (time pattern); Gastrointestinal Hormones; ghrelin; glucagon-like peptide; Health; heart rate variability; Hormones; Human; Ingestion; innovation; Laboratories; meetings; Mental Depression; Methodology; Methods; Modeling; Multicenter Studies; Nerve; neuroregulation; novel; Obesity; obesity treatment; open label; Outcome; Patients; Performance; Phase; Physiologic pulse; polypeptide; public health relevance; Rattus; Reporting; research study; Resistance; Safety; Satiation; Series; Signal Transduction; software development; Stomach; Testing; Time; Training; Vagus nerve structure; Weight; Width

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----